Workflow
Zacks Rank
icon
Search documents
Why Ford Motor Company (F) is a Top Value Stock for the Long-Term
ZACKS· 2026-02-17 15:40
Core Insights - Zacks Premium offers tools for investors to enhance their stock market strategies, including daily updates, research reports, and stock screens [1][2] Zacks Style Scores - Zacks Style Scores provide a rating system for stocks based on value, growth, and momentum, helping investors identify securities likely to outperform the market in the short term [2][3] - Stocks are rated from A to F, with A indicating the highest potential for outperformance [3] Value Score - The Value Style Score focuses on identifying undervalued stocks using financial ratios such as P/E, PEG, and Price/Sales [3] Growth Score - The Growth Style Score assesses a company's financial health and future growth potential by analyzing earnings, sales, and cash flow [4] Momentum Score - The Momentum Style Score evaluates stocks based on price trends and earnings estimate changes, aiding investors in capitalizing on market momentum [5] VGM Score - The VGM Score combines Value, Growth, and Momentum scores, providing a comprehensive indicator for stock selection [6] Zacks Rank - The Zacks Rank is a proprietary model that uses earnings estimate revisions to identify stocks with high potential, with 1 (Strong Buy) stocks historically yielding an average annual return of +23.86% since 1988 [7][9] - There are over 800 stocks rated 1 or 2, making it essential for investors to utilize Style Scores to refine their selections [8] Stock Highlight: Ford Motor Company - Ford is rated 2 (Buy) on the Zacks Rank and has a VGM Score of A, indicating strong investment potential [11] - The company has a forward P/E ratio of 9.28, making it attractive to value investors [11] - Recent earnings estimates for fiscal 2026 have been revised upward, with the consensus estimate increasing by $0.10 to $1.52 per share, and an average earnings surprise of +1.2% [12]
Is Consolidated Edison (ED) Outperforming Other Utilities Stocks This Year?
ZACKS· 2026-02-17 15:40
Group 1: Company Overview - Consolidated Edison (ED) is one of 107 individual stocks in the Utilities sector, ranking 5 in the Zacks Sector Rank [2] - The company currently holds a Zacks Rank of 2 (Buy), indicating a favorable outlook based on earnings estimate revisions [3] Group 2: Performance Metrics - Consolidated Edison has gained approximately 14.5% year-to-date, outperforming the Utilities sector average return of 11.1% [4] - The Zacks Consensus Estimate for ED's full-year earnings has increased by 0.2% over the past quarter, reflecting improved analyst sentiment [4] Group 3: Industry Context - Consolidated Edison belongs to the Utility - Electric Power industry, which includes 58 individual stocks and currently ranks 87 in the Zacks Industry Rank [6] - The Utility - Electric Power industry has gained an average of 12.1% year-to-date, indicating that Consolidated Edison is performing better than its industry peers [6]
Here's Why AT&T (T) is a Strong Value Stock
ZACKS· 2026-02-17 15:40
Core Insights - Zacks Premium provides various tools for investors to enhance their stock market engagement and confidence, including daily updates, research reports, and stock screens [1] Zacks Style Scores - Zacks Style Scores are indicators that rate stocks based on value, growth, and momentum, helping investors identify stocks likely to outperform the market in the short term [2] - Stocks are rated from A to F, with A indicating the highest potential for outperformance [3] Value Score - The Value Score identifies attractive stocks using ratios like P/E, PEG, Price/Sales, and Price/Cash Flow, appealing to value investors seeking undervalued stocks [3] Growth Score - The Growth Score focuses on a company's future prospects and financial health, analyzing earnings, sales, and cash flow to find stocks with sustainable growth [4] Momentum Score - The Momentum Score helps investors capitalize on price trends, using factors like short-term price changes and earnings estimate revisions to identify optimal entry points [5] VGM Score - The VGM Score combines Value, Growth, and Momentum Scores, providing a comprehensive rating to help investors find stocks with the best overall potential [6] Zacks Rank - The Zacks Rank is a proprietary model that uses earnings estimate revisions to guide investors, with 1 (Strong Buy) stocks historically yielding an average annual return of +23.86% since 1988, outperforming the S&P 500 [7] - There can be over 800 stocks rated 1 or 2, making it essential for investors to utilize Style Scores to narrow down choices [8] Stock Example: AT&T Inc. - AT&T Inc. is the second largest wireless service provider in North America, offering a wide range of communication and business solutions [11] - AT&T holds a 3 (Hold) Zacks Rank with a VGM Score of B and a Value Style Score of A, supported by a forward P/E ratio of 12.54, making it attractive for value investors [12] - Recent upward revisions in earnings estimates for fiscal 2026 have increased the Zacks Consensus Estimate by $0.04 to $2.29 per share, with an average earnings surprise of +3.8% [12] - With a solid Zacks Rank and strong Value and VGM Style Scores, AT&T is recommended for investors' consideration [13]
Wall Street Analysts See Cardinal (CAH) as a Buy: Should You Invest?
ZACKS· 2026-02-17 15:31
Core Viewpoint - Brokerage recommendations, particularly for Cardinal Health (CAH), show a strong positive bias, with an average brokerage recommendation (ABR) of 1.25, indicating a consensus between Strong Buy and Buy [2][5]. Group 1: Brokerage Recommendations - Cardinal Health has an ABR of 1.25, based on recommendations from 16 brokerage firms, with 14 of those being Strong Buy, representing 87.5% of all recommendations [2]. - Despite the strong ABR suggesting a buy, relying solely on this information may not be advisable, as studies indicate that brokerage recommendations often fail to guide investors effectively [5][11]. - Analysts from brokerage firms tend to exhibit a positive bias in their ratings, with five "Strong Buy" recommendations for every "Strong Sell" [6][11]. Group 2: Zacks Rank vs. ABR - The Zacks Rank, which classifies stocks from 1 (Strong Buy) to 5 (Strong Sell), is a more reliable indicator of near-term price performance compared to ABR, as it is based on earnings estimate revisions [8][12]. - The Zacks Rank is updated more frequently than ABR, reflecting timely changes in earnings estimates, which are crucial for predicting future stock prices [13]. - Cardinal Health currently holds a Zacks Rank 2 (Buy), supported by a 2.3% increase in the Zacks Consensus Estimate for the current year, now at $10.31 [14][15].
Should Extra Space Storage Stock Be in Your Portfolio Pre-Q4 Earnings?
ZACKS· 2026-02-17 15:26
Core Viewpoint - Extra Space Storage (EXR) is expected to report a year-over-year revenue increase in its fourth-quarter 2025 results, with no change in funds from operations (FFO) per share [1][10]. Financial Performance - In the last reported quarter, EXR achieved an FFO per share of $2.08, exceeding the Zacks Consensus Estimate of $2.06, driven by increased revenues from higher occupancy [2]. - The Zacks Consensus Estimate for quarterly property rental revenues is $731.87 million, up from $707.23 million in the same period last year [4]. - The estimate for revenues from tenant insurance is projected at $88.44 million, an increase from $83.70 million year-over-year [4]. - Management fees and other income are expected to rise to $32.09 million from $30.97 million in the previous year [4]. - Overall, the Zacks Consensus Estimate for total quarterly revenues stands at $864.48 million, indicating a 5.18% year-over-year growth [5][10]. Market Position and Challenges - EXR operates in a fragmented market with significant competition, facing challenges from price-sensitive customers and lower new customer rates, which may impact earnings [5][10]. - The self-storage industry is characterized as need-based and resilient to economic downturns, benefiting from favorable demographic trends [3]. Analyst Sentiment - Over the past four quarters, EXR has beaten the Zacks Consensus Estimate three times, with an average surprise of 0.76% [3]. - However, the consensus estimate for core FFO per share has decreased to $2.03, indicating no change from the previous year [6]. - The current Earnings ESP for EXR is -1.61%, and it holds a Zacks Rank of 4 (Sell), suggesting limited potential for a positive earnings surprise this quarter [8].
Henry Schein Q4 Earnings Preview: What's in Store for the Stock?
ZACKS· 2026-02-17 15:20
Core Insights - Henry Schein, Inc. (HSIC) is set to announce its fourth-quarter 2025 results on February 24, with adjusted earnings per share (EPS) of $1.38 in the last quarter, exceeding the Zacks Consensus Estimate by 8.66% [1] Q4 Estimates for HSIC - The Zacks Consensus Estimate for revenues is $3.33 billion, reflecting a 4.5% increase from the previous year [2] - The Zacks Consensus Estimate for EPS is $1.30, indicating a year-over-year improvement of 9.2% [2] Estimate Revision Trend Ahead of HSIC's Q4 Earnings - Estimates for fourth-quarter earnings have remained stable at $1.30 over the past 90 days [3] Key Factors Driving HSIC's Q4 Performance - The Global Distribution and Value-Added Services segment is expected to show strong sales momentum, particularly in U.S. merchandise and equipment, aided by promotional programs and strong corporate brand sales [4] - The U.S. Medical business is likely to experience solid demand for medical products and pharmaceuticals, with international sales also contributing positively [5] - Revenue from Global Distribution and Value-Added Services is projected to increase by 3.9% year over year [6] Global Specialty Products - Continued strength in implants and biomaterials, as well as endodontics, is anticipated to enhance fourth-quarter performance, with significant contributions from S.I.N and Biotech Dental implant systems [7] - U.S. implant and biomaterials sales are expected to benefit from the BioHorizons Tapered Pro Conical implant and SmartShape Healers abutment [8] - Global Specialty Products revenues are expected to grow by 5.9% year over year [11] Global Technology - Sales in this segment are likely driven by growth in Core Practice Management System Solutions, particularly cloud-based platforms, and revenue cycle management offerings [12] - Global Technology revenues are projected to increase by 9.7% year over year [13]
Kite Realty Group (KRG) Meets Q4 FFO Estimates
ZACKS· 2026-02-17 15:16
Core Viewpoint - Kite Realty Group reported quarterly funds from operations (FFO) of $0.51 per share, matching the Zacks Consensus Estimate, but down from $0.53 per share a year ago, indicating a slight decline in performance [1] Financial Performance - The company posted revenues of $204.94 million for the quarter ended December 2025, missing the Zacks Consensus Estimate by 1.6%, compared to $214.72 million in the same quarter last year [2] - Over the last four quarters, Kite Realty Group has surpassed consensus FFO estimates two times and topped consensus revenue estimates two times [2] Stock Performance - Kite Realty Group shares have increased approximately 4.4% since the beginning of the year, while the S&P 500 has declined by 0.1% [3] - The stock's immediate price movement will depend on management's commentary during the earnings call and future FFO expectations [3] Future Outlook - The current consensus FFO estimate for the coming quarter is $0.51 on revenues of $204.55 million, and for the current fiscal year, it is $2.09 on revenues of $830.43 million [7] - The estimate revisions trend for Kite Realty Group was unfavorable prior to the earnings release, resulting in a Zacks Rank 4 (Sell) for the stock, indicating expected underperformance in the near future [6] Industry Context - The REIT and Equity Trust - Retail industry is currently ranked in the top 26% of over 250 Zacks industries, suggesting a favorable outlook compared to the bottom half [8]
Oncobiologics, Inc. (OTLK) Reports Q1 Loss, Misses Revenue Estimates
ZACKS· 2026-02-17 15:16
分组1 - Oncobiologics, Inc. reported a quarterly loss of $0.22 per share, which was worse than the Zacks Consensus Estimate of a loss of $0.17, representing an earnings surprise of -26.95% [1] - The company posted revenues of -$1.21 million for the quarter ended December 2025, missing the Zacks Consensus Estimate by 131.38%, compared to zero revenues a year ago [2] - Oncobiologics shares have declined approximately 69% since the beginning of the year, contrasting with the S&P 500's decline of only 0.1% [3] 分组2 - The current consensus EPS estimate for the upcoming quarter is -$0.16 on revenues of $4.97 million, and for the current fiscal year, it is -$0.65 on revenues of $21.13 million [7] - The Medical - Biomedical and Genetics industry, to which Oncobiologics belongs, is currently ranked in the top 34% of over 250 Zacks industries, indicating a favorable outlook compared to the bottom 50% [8]
3 Leisure Stocks Set to Outperform Q4 Earnings Expectations
ZACKS· 2026-02-17 15:01
Industry Overview - The leisure industry experienced resilient consumer demand in Q4 2025, driven by steady employment and a preference for experiences over goods, particularly during the holiday season [1] - Strong booking trends for leisure travel, increased attendance at events, and solid visitation at resorts, casinos, theme parks, and cruises contributed to revenue growth [1] Pricing Strategies - Leisure operators utilized dynamic pricing, premium offerings, and bundled experiences to counteract softer traffic, leading to higher average revenue per customer [2] - Increased room rates, onboard spending, ticket pricing, and ancillary revenues helped sustain revenue growth despite modest volume increases [2] Cost Management - The bottom line benefited from easing inflationary pressures, improved labor availability, and operational efficiencies, including streamlined staffing and technology-driven productivity gains [3] - Lower energy and input cost volatility further stabilized operating expenses [3] Financial Discipline - Disciplined capital allocation and balance sheet management supported profitability, allowing companies to focus on margin-accretive growth without aggressive discounting [4] - Healthier financial positions enabled companies to translate solid revenues into stronger earnings [4] Company Highlights - Pool Corporation is set to report Q4 2025 results with an Earnings ESP of +1.10% and projected EPS of 99 cents, up from 97 cents a year ago [7][10] - Hilton Grand Vacations is expected to report Q4 2025 results with an Earnings ESP of +1.19% and projected EPS of $1.05, compared to 49 cents last year [10][11] - PENN Entertainment is anticipated to report a narrower loss of 20 cents per share for Q4 2025, with an Earnings ESP of +7.03% [12][14]
Earnings Preview: International General Insurance Holdings Ltd. (IGIC) Q4 Earnings Expected to Decline
ZACKS· 2026-02-17 15:00
Core Viewpoint - International General Insurance Holdings Ltd. (IGIC) is anticipated to report a year-over-year decline in earnings despite an increase in revenues for the quarter ending December 2025, which could significantly influence its stock price depending on the actual results compared to estimates [1][2]. Earnings Expectations - The upcoming earnings report is expected to be released on February 24, with a consensus estimate of $0.72 per share, reflecting a year-over-year decrease of 19.1%. Revenues are projected to be $138.2 million, representing a 2.2% increase from the previous year [3][2]. Estimate Revisions - The consensus EPS estimate has remained unchanged over the last 30 days, indicating that analysts have not significantly altered their initial projections during this period [4]. Earnings Surprise Prediction - The Zacks Earnings ESP (Expected Surprise Prediction) model indicates that the Most Accurate Estimate for IGIC is the same as the Zacks Consensus Estimate, resulting in an Earnings ESP of 0%. This suggests a lack of recent differing analyst views [11]. Historical Performance - In the last reported quarter, IGIC was expected to post earnings of $0.91 per share but actually reported $0.87, resulting in a surprise of -4.40%. Over the past four quarters, the company has only beaten consensus EPS estimates once [13][14]. Investment Considerations - While IGIC does not appear to be a strong candidate for an earnings beat, investors are advised to consider other factors that may influence stock performance ahead of the earnings release [17].